Business Description
Futura Medical PLC
ISIN : GB0033278473
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.46 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.16 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -24.2 | |||||
3-Year EPS without NRI Growth Rate | -30.1 | |||||
3-Year FCF Growth Rate | 46 | |||||
3-Year Book Growth Rate | 81.7 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 70.12 | |||||
9-Day RSI | 57.47 | |||||
14-Day RSI | 51.63 | |||||
6-1 Month Momentum % | 25.08 | |||||
12-1 Month Momentum % | -23.91 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.47 | |||||
Quick Ratio | 1.47 | |||||
Cash Ratio | 1.22 | |||||
Days Inventory | 0.28 | |||||
Days Sales Outstanding | 86.83 | |||||
Days Payable | 183.1 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.1 | |||||
Shareholder Yield % | -4.1 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 57.21 | |||||
Operating Margin % | -224.57 | |||||
Net Margin % | -210.03 | |||||
FCF Margin % | -30.18 | |||||
ROE % | -107.3 | |||||
ROA % | -68.57 | |||||
ROIC % | -162.02 | |||||
ROC (Joel Greenblatt) % | -440.48 | |||||
ROCE % | -114.73 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 33.45 | |||||
PB Ratio | 20.44 | |||||
Price-to-Tangible-Book | 18.4 | |||||
Price-to-Operating-Cash-Flow | 184 | |||||
EV-to-EBIT | -14.82 | |||||
EV-to-EBITDA | -15.1 | |||||
EV-to-Forward-EBITDA | -30.69 | |||||
EV-to-Revenue | 33.29 | |||||
EV-to-Forward-Revenue | 11.25 | |||||
EV-to-FCF | -110.28 | |||||
Price-to-Net-Current-Asset-Value | 36.8 | |||||
Earnings Yield (Greenblatt) % | -6.75 | |||||
FCF Yield % | -0.84 |